MMP-9-C1562T polymorphism and susceptibility to chronic obstructive pulmonary disease: A meta-analysis

Rongrong Zhao1, Houxiu Zhou, Jingci Zhu

  • 1Department of Nursing, Army Medical University (Third Military Medical University), Chong Qing, China.

Medicine
|August 7, 2020
PubMed
Abstract

Insights

The matrix metalloproteinase-9 (MMP-9) C1562T gene polymorphism is linked to chronic obstructive pulmonary disease (COPD) risk in middle-aged and elderly individuals. The C allele increases COPD susceptibility, particularly in Caucasians, while the T allele shows a protective effect.

Area of Science:

  • Genetics
  • Pulmonology
  • Molecular Biology

Background:

  • Chronic obstructive pulmonary disease (COPD) is a major global health concern.
  • Genetic factors, including matrix metalloproteinase-9 (MMP-9) gene polymorphisms, are implicated in COPD susceptibility.
  • The MMP-9 C1562T (rs3918242) polymorphism has been investigated for its association with COPD risk.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the association between the MMP-9 C1562T polymorphism and COPD susceptibility.
  • To assess the role of this polymorphism in middle-aged and elderly COPD patients.
  • To explore ethnic differences in the MMP-9 C1562T polymorphism's association with COPD.

Main Methods:

  • A comprehensive literature search was performed across multiple databases (PubMed, EMBASE, CNKI, Wanfang, VIP) up to August 2019.
  • Case-control studies investigating the MMP-9 C1562T polymorphism and COPD were included.
  • Meta-analysis was conducted using Stata 15.0, including subgroup and sensitivity analyses, and publication bias tests.

Main Results:

  • The meta-analysis included 13 studies with 2512 cases and 2716 controls.
  • A significant association was found between the MMP-9 C1562T polymorphism and COPD susceptibility (OR=0.35, P<.01).
  • Subgroup analysis revealed a stronger association in Caucasians (OR=0.24, P<.01) but not in Asians (OR=0.62, P>.05).

Conclusions:

  • The MMP-9 C1562T polymorphism is associated with COPD susceptibility in middle-aged and elderly populations.
  • The C allele appears to increase COPD risk, especially in Caucasians.
  • No significant association was observed in the Asian population.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.0K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.3K